Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Post by longterm56on Apr 05, 2020 2:18pm
204 Views
Post# 30880866

A Good Plan Gone Bad

A Good Plan Gone BadI was one of those who took advantage of the low share price to convert my THTX holdings from an IRA to a Roth IRA, meaning I pay the taxes now on the low value hoping it will increase and then will be free from tax upon withdrawal. 

This is how that grand idea worked out  ....

Since I did this in December & January (split across two tax years) and since the share price is about 1/2 of what it was when I converted, that effectively doubles the tax rate I paid (if one considers today's balance) ... from 24% to 48% ... OUCH!   I don't think I'll get the "Most Prudent Investor of the Year Award" this time. 

This wound will heal quickly if the share price recovers, but it is a gaping and painful gash at the moment as I write the estimated tax check that is due on April 15. 

   -LT

PS: I had a glimmer of hope when I saw one could reverse a Roth conversion, but this opportunity was eliminated in 2018 and beyond. 



Bullboard Posts